Kalms Consulting is pleased to announce a new professional cooperation with Prof. Dr. Eva Susanne Dietrich, who will support Kalms Consulting as an Associate Partner.
With her “Institut für evidenzbasierte Positionierung im Gesundheitswesen”, Prof. Dr. Dietrich brings extensive expertise in the pharmaceutical sector, with a particular focus on AMNOG, early benefit assessment, benefit law, G-BA practice, and strategic positioning.
This cooperation strengthens Kalms Consulting’s ability to support clients at the interface of evidence generation, benefit assessment, market access, reimbursement, and strategic healthcare positioning.
Combining complementary expertise
Kalms Consulting supports companies in healthcare, MedTech, life sciences, diagnostics and selected pharmaceutics with services including market access, reimbursement strategy, MDR/IVDR, regulatory strategy, commercialization, and international expansion.
Many healthcare projects are located at complex interfaces. Evidence requirements, benefit assessment, reimbursement methods, regulatory expectations and strategic market positioning often need to be considered together at an early stage.
By working with Prof. Dr. Dietrich, Kalms Consulting can further extend its professional perspective, particularly for projects in the pharmaceutical sector and interdisciplinary projects where pharmaceutical, medical device, regulatory and market access questions overlap.
Supporting clients from strategy to implementation
The cooperation reflects Kalms Consulting’s broader approach: helping clients move from market entry to market success.
In increasingly regulated and evidence-driven healthcare markets, successful commercialization requires more than meeting formal requirements. Companies need a clear understanding of stakeholder expectations, reimbursement pathways, evidence needs, and practical implementation requirements.
We are very pleased to welcome Prof. Dr. Eva Susanne Dietrich to its network of Associate Partners.
Contact
For further information or to discuss a potential project, please contact the Kalms Consulting team.
Published on: June 4, 2026
